WELL Health Technologies Corp. (TSE:WELL) Given Consensus Rating of “Moderate Buy” by Analysts

WELL Health Technologies Corp. (TSE:WELL) has been given an average rating of “Moderate Buy” by the seven analysts that are presently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year price target among brokers that have covered the stock in the last year is C$7.39.

WELL has been the subject of several recent research reports. Pi Financial boosted their price target on shares of WELL Health Technologies from C$8.25 to C$8.50 in a research note on Wednesday, January 31st. Royal Bank of Canada set a C$5.50 price objective on shares of WELL Health Technologies and gave the company an “outperform” rating in a research report on Tuesday, February 6th. Finally, CIBC cut shares of WELL Health Technologies from an “outperform” rating to a “neutral” rating and decreased their price objective for the company from C$5.50 to C$4.75 in a research report on Monday, January 22nd.

WELL Health Technologies Stock Performance

WELL Health Technologies stock opened at C$3.52 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.15 and a debt-to-equity ratio of 50.38. The company has a market capitalization of C$864.62 million, a PE ratio of -185.00, a P/E/G ratio of -1.93 and a beta of 1.27. The firm has a fifty day simple moving average of C$3.81 and a two-hundred day simple moving average of C$3.87. WELL Health Technologies has a twelve month low of C$3.41 and a twelve month high of C$5.94.

About WELL Health Technologies

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.